Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102040625B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.